Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen W Lagakos

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|June 28, 2006
Time-to-event analyses for long-term treatments--the APPROVe trialStephen W Lagakos
The New England Journal of Medicine|April 21, 2006
The challenge of subgroup analyses--reporting without distortingStephen W Lagakos
The New England Journal of Medicine|June 13, 2003
Clinical trials and rare diseasesStephen W Lagakos
The Canadian Journal of Statistics = Revue Canadienne De Statistique|April 7, 2010
Inference after variable selection using restricted permutation methodsRui Wang, Stephen W Lagakos
Statistics in Medicine|November 10, 2004
Evaluation of log-rank tests for infrequent observations from a multi-state process, with application to HPV vaccine efficacyMinhee Kang, Stephen W Lagakos
Statistical Methods in Medical Research|April 8, 2004
Evaluating the role of human papillomavirus vaccine in cervical cancer preventionMinhee Kang, Stephen W Lagakos
Biometrics|April 29, 2009
Estimating HIV incidence based on combined prevalence testingRaji Balasubramanian, Stephen W Lagakos
Journal of Acquired Immune Deficiency Syndromes (1999)|November 3, 2009
On the use of adjusted cross-sectional estimators of HIV incidenceRui Wang, Stephen W Lagakos
Biometrics|November 17, 2009
Augmented cross-sectional prevalence testing for estimating HIV incidenceRui Wang, Stephen W Lagakos
Biometrics|June 8, 2004
Analyzing time-to-event data in a clinical trial when an unknown proportion of subjects has experienced the event at entryRaji Balasubramanian, Stephen W Lagakos
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|June 28, 2006
Time-to-event analyses for long-term treatments--the APPROVe trialStephen W Lagakos
The New England Journal of Medicine|April 21, 2006
The challenge of subgroup analyses--reporting without distortingStephen W Lagakos
The New England Journal of Medicine|June 13, 2003
Clinical trials and rare diseasesStephen W Lagakos
The Canadian Journal of Statistics = Revue Canadienne De Statistique|April 7, 2010
Inference after variable selection using restricted permutation methodsRui Wang, Stephen W Lagakos
Statistics in Medicine|November 10, 2004
Evaluation of log-rank tests for infrequent observations from a multi-state process, with application to HPV vaccine efficacyMinhee Kang, Stephen W Lagakos
Statistical Methods in Medical Research|April 8, 2004
Evaluating the role of human papillomavirus vaccine in cervical cancer preventionMinhee Kang, Stephen W Lagakos
Biometrics|April 29, 2009
Estimating HIV incidence based on combined prevalence testingRaji Balasubramanian, Stephen W Lagakos
Journal of Acquired Immune Deficiency Syndromes (1999)|November 3, 2009
On the use of adjusted cross-sectional estimators of HIV incidenceRui Wang, Stephen W Lagakos
Biometrics|November 17, 2009
Augmented cross-sectional prevalence testing for estimating HIV incidenceRui Wang, Stephen W Lagakos
Biometrics|June 8, 2004
Analyzing time-to-event data in a clinical trial when an unknown proportion of subjects has experienced the event at entryRaji Balasubramanian, Stephen W Lagakos
Pageof 3